
# Title 42 - Public Health
## Chapter IV - Centers for Medicare & Medicaid Services, Department of Health and Human Services
### Subchapter G - Standards and Certification
#### PART 494 - CONDITIONS FOR COVERAGE FOR END-STAGE RENAL DISEASE FACILITIES
##### Subpart B - Patient Safety
###### ยง 494.50 Condition: Reuse of hemodialyzers and bloodlines.
####### Standard: Monitoring, evaluation, and reporting requirements for the reuse of hemodialyzers and bloodlines.

(c)In addition to the requirements for hemodialyzer and bloodline reuse specified in paragraphs (a) and (b) of this section, the dialysis facility must adhere to the following:

(1) Monitor patient reactions during and following dialysis.

(2) When clinically indicated (for example, after adverse patient reactions), the facility must-

(i) Obtain blood and dialysate cultures and endotoxin levels; and

(ii) Undertake evaluation of its dialyzer reprocessing and water purification system. When this evaluation suggests a cluster of adverse patient reactions is associated with hemodialyzer reuse, the facility must suspend reuse of hemodialyzers until it is satisfied the problem has been corrected.

(iii) Report the adverse outcomes to the FDA and other Federal, State or local government agencies as required by law.
